These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6373045)

  • 1. Formaldehyde as a possible mutagenic metabolite of N-nitrodimethylamine and of other agents which are suggested to yield non-alkylating species in vitro.
    Pool BL; Frei E; Plesch WJ; Romruen K; Wiessler M
    Carcinogenesis; 1984 Jun; 5(6):809-14. PubMed ID: 6373045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivatives.
    Frei E; Pool BL; Plesch W; Wiessler M
    IARC Sci Publ; 1984; (57):491-7. PubMed ID: 6398301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylation and nitroreduction are required to activate dimethylnitramine into alkylating and mutagenic agents.
    Malaveille C; Croisy A; Brun G; Bartsch H
    Carcinogenesis; 1983 Nov; 4(11):1477-81. PubMed ID: 6357524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic activation and the mutagenic properties of carcinogenic N-nitramines in a liquid incubation test].
    Khudoleĭ VV; Bartsch H; Malaveille C
    Vopr Onkol; 1981; 27(12):47-51. PubMed ID: 7034364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines].
    Khudoleĭ VV; Malaveille C; Bartsch H
    Vopr Onkol; 1981; 27(11):59-62. PubMed ID: 7039103
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic and mutagenic effects of formaldehyde in Salmonella typhimurium.
    Temcharoen P; Thilly WG
    Mutat Res; 1983 Feb; 119(2):89-93. PubMed ID: 6338371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity experiments on agroclavines, new natural antineoplastic compounds.
    Glatt H; Eich E; Pertz H; Becker C; Oesch F
    Cancer Res; 1987 Apr; 47(7):1811-4. PubMed ID: 3545454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of DNA single strand breaks and selective DNA amplification by N-nitrodimethylamine and analogs, and estimation of the indicator cells' metabolic capacities.
    Frei E; Pool BL; Glatt HR; Gemperlein-Mertes I; Oesch F; Schlehofer JR; Schmezer P; Weber H; Wiessler M
    J Cancer Res Clin Oncol; 1986; 111(2):123-8. PubMed ID: 3009487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic effects of isoniazid and the relationship to in vivo and in vitro biotransformation.
    Braun R; Jäkel HP; Schöneich J
    Mutat Res; 1984; 137(2-3):61-9. PubMed ID: 6381996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial mutagenicity of selected hydrazines.
    Rogan EG; Walker BA; Gingell R; Nagel DL; Toth B
    Mutat Res; 1982 Dec; 102(4):413-24. PubMed ID: 6757742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of biotransformation of 2,4-dinitrotoluene on its mutagenic potential.
    Couch DB; Abernethy DJ; Allen PF
    Mutagenesis; 1987 Nov; 2(6):415-8. PubMed ID: 3328032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity of benzylating N-nitroso compounds. Models of activated N-nitrosomethylbenzylamine.
    Wiessler M; Romruen K; Pool BL
    Carcinogenesis; 1983; 4(7):867-71. PubMed ID: 6223716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenic activity and specificity of N-nitrosomethylaniline and N-nitrosodiphenylamine in Salmonella.
    Zielenska M; Guttenplan JB
    Mutat Res; 1988 Nov; 202(1):269-76. PubMed ID: 3054528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.